EGFR and glioblastoma: Moreover, loss of Anxa7 tumor suppressor expression with gain in epidermal growth factor receptor protein induced survival signaling pathway and reported earlier, demonstrated to be a high risk factor in evaluating the survival of glioblastoma patient [11, 13].